Back to dashboard
MedicaidCoverageMedium impact

Coverage of Buprenorphine Injection

Maryland Medicaid·MD · Psychiatry, Family Medicine, Internal Medicine·Provider Transmittal
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Maryland Medicaid has updated coverage policies for buprenorphine injection, a medication used for opioid use disorder treatment. This affects billing and coverage requirements for providers administering this medication to Maryland Medicaid patients.

Action Required

Action needed
Immediately: Review the full policy document at the provided URL to understand specific coverage criteria, prior authorization requirements, and billing procedures for buprenorphine injection for Maryland Medicaid patients. Update billing workflows and staff training accordingly based on the detailed policy requirements.